TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study

Autor: A. J. M. Meijer, F. A. Diepstraten, T. Langer, L. Broer, I. K. Domingo, E. Clemens, A. G. Uitterlinden, A. C. H. de Vries, M. van Grotel, W. P. Vermeij, R. A. Ozinga, H. Binder, J. Byrne, E. van Dulmen-den Broeder, M. L. Garrè, D. Grabow, P. Kaatsch, M. Kaiser, L. Kenborg, J. F. Winther, C. Rechnitzer, H. Hasle, T. Kepak, K. Kepakova, W. J. E. Tissing, A. L. F. van der Kooi, L. C. M. Kremer, J. Kruseova, S. M. F. Pluijm, C. E. Kuehni, H. J. H. van der Pal, R. Parfitt, C. Spix, A. Tillmanns, D. Deuster, P. Matulat, G. Calaminus, A. E. Hoetink, S. Elsner, J. Gebauer, R. Haupt, H. Lackner, C. Blattmann, S. J. C. M. M. Neggers, S. R. Rassekh, G. E. B. Wright, B. Brooks, A. P. Nagtegaal, B. I. Drögemöller, C. J. D. Ross, A. P. Bhavsar, A. G. am Zehnhoff-Dinnesen, B. C. Carleton, O. Zolk, M. M. van den Heuvel-Eibrink, the PanCareLIFE Consortium, and the CPNDS Consortium

Publikováno v: npj Precision Oncology, Vol 5, Iss 1, Pp 1-8 (2021)

Abstract In children with cancer, the heterogeneity in ototoxicity occurrence after similar treatment suggests a role for genetic susceptibility. Using a genome-wide association study (GWAS) approach, we identified a genetic variant in TCERG1L (rs893

Externí odkaz: https://doaj.org/article/1a21ee1f4f0440f184693f4b2b482abf

Ten-year experience of a national multidisciplinary tumour board for cancer and pregnancy in the Netherlands

Autor: Joosje H. Heimovaara, Ingrid A. Boere, Jorine de Haan, Kristel van Calsteren, Frédéric Amant, Lia van Zuylen, Christine A.R. Lok, C.A.R. Lok, L. van Zuylen, I.A. Boere, F. Amant, C.C.M. Beerendonk, M. Bellido-Casado, J.J. Beltman, M.E.M.M. Bos, J.J. Duvekot, C.G., Gerestein, S. Gordijn, C.J.M. de Groot, M. van Grotel, S.N. Han, B.C. Heeres, M.M. van den Heuvel-Eibrink, A. Houwink, D.R. Huitema, PhW. Koken, L.B. Koppert, P.J. Lugtenburg, P.B. Ottevanger, R.C. Painter, P.M.P. Poortmans, E.M. Roes, L. van der Scheer, C.P. Schröder, B.B.M. Suelmann, K.P.M. Suijkerbuijk, G. van Tienhoven, N.E. van Trommel, J.W. Trum, J. van der Velden, I.J.H. Vriens, P.O. Witteveen

Publikováno v: Heimovaara, J H, Boere, I A, de Haan, J, van Calsteren, K, Amant, F, van Zuylen, L, Lok, C A R, the Dutch Advisory Board for Cancer during Pregnancy, Lok, C A R, van Zuylen, L, Boere, I A, Amant, F, Beerendonk, C C M, Bellido-Casado, M, Beltman, J J, Bos, M E M M, Duvekot, J J, Gerestein, C G, Gordijn, S, de Groot, C J M, van Grotel, M, Han, S N, Heeres, B C, van den Heuvel-Eibrink, M M, Houwink, A, Huitema, D R, Koken, P, Koppert, L B, Lugtenburg, P J, Ottevanger, P B, Painter, R C, Poortmans, P M P, Roes, E M, van der Scheer, L, Schröder, C P, Suelmann, B B M, Suijkerbuijk, K P M, van Tienhoven, G, van Trommel, N E, Trum, J W, van der Velden, J, Vriens, I J H & Witteveen, P O 2022, ' Ten-year experience of a national multidisciplinary tumour board for cancer and pregnancy in the Netherlands ', European Journal of Cancer, vol. 171, pp. 13-21 . https://doi.org/10.1016/j.ejca.2022.04.040
European Journal of Cancer, 171, 13-21. Pergamon
European Journal of Cancer, 171, 13-21. Elsevier Ltd.
European Journal of Cancer, 171, 13-21. ELSEVIER SCI LTD
European Journal of Cancer, 171, 13-21
European Journal of Cancer, 171, pp. 13-21
European Journal of Cancer, 171, 13-21. Elsevier Limited

Contains fulltext : 252036.pdf (Publisher’s version ) (Closed access) BACKGROUND: Most physicians encounter pregnant women with cancer incidentally, leading to a lack of expertise or confidence to inform and treat these patients based on the most r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb870c0ecb6e659780a111f08cb40158
https://doi.org/10.1016/j.ejca.2022.04.040

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Prognostic significance of age in 5631 patients with Wilms tumour prospectively registered in International Society of Paediatric Oncology (SIOP) 93-01 and 2001.

Autor: J A Hol, M I Lopez-Yurda, H Van Tinteren, M Van Grotel, J Godzinski, G Vujanic, F Oldenburger, B De Camargo, G L Ramírez-Villar, C Bergeron, K Pritchard-Jones, N Graf, M M Van den Heuvel-Eibrink

Publikováno v: PLoS ONE, Vol 14, Iss 8, p e0221373 (2019)

BackgroundTo enhance risk stratification for Wilms tumour (WT) in a pre-operative chemotherapy setting, we explored the prognostic significance and optimal age cutoffs in patients treated according to International Society of Paediatric Oncology Rena

Externí odkaz: https://doaj.org/article/832b66d90e5e48309fa7573090bd810d